Nuzenio

Amylyx Pharmaceuticals Reports

Amylyx Pharmaceuticals Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 15:48:02 GMTAmylyx Pharmaceuticals (NASDAQ:AMLX) Issues Earnings Results, Misses Estimates By $0.03 EPS - MarketBeatMarketBeat · Fri, 07 Aug 2026 02:14:15 GMTAmylyx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:52:32 GMTAmylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:02:42 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMTAmylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 12-Month High on Analyst Upgrade - MarketBeatMarketBeat · Tue, 04 Aug 2026 14:54:12 GMT

Timeline

Fri, 07 Aug 2026 15:48:02 GMTAmylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore
Fri, 07 Aug 2026 02:14:15 GMTAmylyx Pharmaceuticals (NASDAQ:AMLX) Issues Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Thu, 06 Aug 2026 14:52:32 GMTAmylyx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 06 Aug 2026 13:02:42 GMTAmylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 11:11:00 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Amylyx Pharmaceuticals Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.